SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+9.57%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.65B
AUM Growth
+$1.65B
(+4.6%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
10.04%
Top 10 Holdings %
Top 10 Hldgs %
69.29%
Holding
60
New
5
Increased
18
Reduced
9
Closed
10
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$47M |
| 2 |
Ascendis Pharma
ASND
|
$46.5M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$45.3M |
| 4 |
Sanofi
SNY
|
$33.9M |
| 5 |
Align Technology
ALGN
|
$17.5M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$29.8M |
| 2 |
Intuitive Surgical
ISRG
|
$18.1M |
| 3 |
iRhythm Technologies
IRTC
|
$17.6M |
| 4 |
United Therapeutics
UTHR
|
$16.2M |
| 5 |
Eli Lilly
LLY
|
$14.7M |
Sector Composition
| 1 | Healthcare | 99.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arcutis Biotherapeutics
ARQT
$1.91B
| – | – |
-274,330
| Closed | -$5.24M |
|
52
Edwards Lifesciences
EW
$47.7B
| – | – |
-147,200
| Closed | -$12.2M |
|
|
53
iRhythm Technologies
IRTC
$5.67B
| – | – |
-140,095
| Closed | -$17.6M |
|
|
54
Eli Lilly
LLY
$661B
| – | – |
-45,500
| Closed | -$14.7M |
|
55
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
56
Regenxbio
RGNX
$498M
| – | – |
-213,959
| Closed | -$5.66M |
|
57
Health Care Select Sector SPDR Fund
XLV
$33.8B
| – | – |
0
| – | – |
|
|
NGM
58
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – |
0
| – | – |
|
|
AKUS
59
DELISTED
Akouos, Inc. Common Stock
AKUS
| – | – |
-1,515,074
| Closed | -$10.2M |
|